$19.9B
$1.77 Billion
11.1% of portfolio
3,665,000
Q3 2025
New
$55.8B
$968 Million
6.07% of portfolio
4,800,000
Q3 2025
New
$65.7B
$826 Million
5.18% of portfolio
2,750,000
Q3 2025
New
$28.3B
$820 Million
5.14% of portfolio
10,000,000
Q3 2025
Added 12.23%
$6.52B
$565 Million
3.55% of portfolio
5,300,000
Q3 2025
New
$114B
$538 Million
3.38% of portfolio
2,494,800
Q3 2025
Added 21.7%
$55.9B
$528 Million
3.31% of portfolio
27,060,000
Q3 2025
New
$6.66B
$508 Million
3.18% of portfolio
3,163,000
Q3 2025
Added 39.34%
$3.85B
$363 Million
2.28% of portfolio
9,400,000
Q3 2025
Added 5.03%
$9.88B
$355 Million
2.23% of portfolio
5,500,000
Q3 2025
New
$0
$266 Million
1.67% of portfolio
400,000
Q3 2025
Added 73.91%
$1.37B
$253 Million
1.59% of portfolio
11,681,000
Q3 2025
Added 66.87%
$14.9B
$210 Million
1.32% of portfolio
997,000
Q3 2025
Added 115.33%
$5.92B
$183 Million
1.14% of portfolio
7,350,000
Q3 2025
Added 7.76%
$690M
$172 Million
1.08% of portfolio
11,750,000
Q3 2025
New
$6.2B
$170 Million
1.06% of portfolio
2,672,000
Q2 2025
Added 141.16%
$7.09B
$140 Million
0.88% of portfolio
2,200,000
Q3 2025
New
$21.4B
$127 Million
0.8% of portfolio
2,900,000
Q3 2025
Added 7,150.0%
$29B
$124 Million
0.78% of portfolio
4,300,000
Q3 2025
Added 3.61%
$4.72B
$121 Million
0.76% of portfolio
2,285,000
Q3 2025
Added 140.53%
$136B
$108 Million
0.68% of portfolio
253,400
Q3 2025
Added 58.38%
$1.89B
$106 Million
0.67% of portfolio
5,186,000
Q3 2025
Added 60.56%
$4.4B
$91.3 Million
0.57% of portfolio
970,000
Q3 2025
New
$300B
$69.1 Million
0.43% of portfolio
200,000
Q3 2025
Reduced 79.49%
$38B
$54.2 Million
0.34% of portfolio
400,000
Q3 2025
Reduced 10.11%
$2.39B
$48.9 Million
0.31% of portfolio
640,000
Q3 2025
New
$3.57B
$49.6 Million
0.31% of portfolio
1,190,000
Q3 2025
Added 5.68%
$4.44B
$47.3 Million
0.3% of portfolio
2,326,300
Q3 2025
New
$1.23B
$46.6 Million
0.29% of portfolio
6,009,500
Q3 2025
New
$6.81B
$42.5 Million
0.27% of portfolio
453,550
Q3 2025
New
$9.26B
$43 Million
0.27% of portfolio
1,152,000
Q3 2025
Reduced 70.98%
$1.63B
$39.2 Million
0.25% of portfolio
1,170,000
Q3 2025
New
$20.8B
$22.3 Million
0.14% of portfolio
110,000
Q3 2025
New
$3.35B
$16.6 Million
0.1% of portfolio
598,300
Q3 2025
New
$6.25B
$16.5 Million
0.1% of portfolio
300,000
Q2 2025
Added 36.36%
$1.2B
$15.7 Million
0.1% of portfolio
1,250,000
Q3 2025
Reduced 51.83%
$1.44B
$13.1 Million
0.08% of portfolio
2,001,400
Q3 2025
New
$926M
$10.8 Million
0.07% of portfolio
170,000
Q2 2025
Added 39.23%
$404M
$10.2 Million
0.06% of portfolio
1,476,000
Q3 2025
New
$1.05B
$5.73 Million
0.04% of portfolio
250,000
Q3 2025
New
$8.12B
$1.35 Million
0.01% of portfolio
25,000
Q3 2025
New
$451M
$1.39 Million
0.01% of portfolio
75,000
Q3 2025
Added 50.0%
$2.13B
$1.96 Million
0.01% of portfolio
60,000
Q3 2025
New
$1.43B
$1.27 Million
0.01% of portfolio
120,000
Q3 2025
New
$18.8M
$1.07 Million
0.01% of portfolio
724,856
Q3 2025
Reduced 11.06%
$2.27B
$155,000
0.0% of portfolio
8,000
Q3 2025
New
Esperion Therapeutics Inc Ne
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 59.57%
$38.4B
$637,000
0.0% of portfolio
25,000
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 2,351.16%